Filgrastim for Recurrent Ovarian Cancer
Links shared publicly online about this topic
First Recurrent Gene Fusion Identified In Ovarian Cancer
medicalnewstoday.com — “Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2011 at 7:05 am By:
MNT Ovarian Cancer Health News
First Recurrent Gene Fusion Identified In Ovarian Cancer http://mnt.to/3ZMY #ovariancancer
Ovarian cancer vaccine: Can it prevent recurrence? - MayoClinic.com
mayoclinic.com — “Research continues to evaluate the role of an ovarian cancer vaccine to prevent recurrence.” View full resource at mayoclinic.com
Most Recently Shared on March 24, 2012 at 2:20 am By:
Julie Bohlen Health Executive and Active Health Library
Ovarian cancer vaccine: Can it prevent recurrence?: Research continues to evaluate the role of an ovarian cancer... http://t.co/fbwU0zDZ
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer
medicalnewstoday.com — “Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2011 at 9:07 am By:
MNT Ovarian Cancer Health News
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer http://t.co/7OgdD8rC #ovariancancer
Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer
onclive.com — “Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in PFS when bevacizumab was added to chemotherapy and continued as maintenance therapy.” View full resource at onclive.com
Most Recently Shared on July 27, 2011 at 7:45 pm By:
Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer http://t.co/gLOIrDB
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA
oncologynurseadvisor.com — “The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 5, 2011 at 5:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - ONA
oncologynurseadvisor.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 7, 2010 at 8:20 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer http://goo.gl/fb/vAkMj
Dr. Karlan Discusses AMG 386 in Recurrent Ovarian Cancer
onclive.com — “Beth Y. Karlan MD Discusses AMG 386 in Recurrent Ovarian Cancer” View full resource at onclive.com
Most Recently Shared on May 5, 2011 at 6:51 pm By:
OncLive TV: Dr. Beth Karlan from @CedarsSinai Discusses AMG 386 in Recurrent Ovarian Cancer http://goo.gl/eO2xa
Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - MPR
empr.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.” View full resource at empr.com
Most Recently Shared on June 7, 2010 at 8:14 pm By:
MPR News: Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer: Amgen announced that AMG 386, combin... http://bit.ly/cBbIUj
Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on June 5, 2011 at 11:58 pm By:
Miriam E. Tucker Patient Expert
RT @IntMedNews: Bevacizumab Halves Progression Risk in Recurrent Ovarian #Cancer http://bit.ly/ipBNsP
Detecting breast cancer recurrence
physorg.com — “Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain and ovarian cancer before succumbing to the disease in their early ...” View full resource at physorg.com
Most Recently Shared on October 20, 2010 at 3:12 pm By:
Detecting breast cancer recurrence http://bit.ly/9do9jO
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
hindawi.com — “Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer” View full resource at hindawi.com
Most Recently Shared on August 29, 2011 at 6:40 pm By:
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer: Thi... http://t.co/C0fygZk
Oncology Article | ovarian cancer
mdlinx.com — “Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort” View full resource at mdlinx.com
Most Recently Shared on September 1, 2011 at 10:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive su... http://t.co/VTK4Upu #oncology
Oncology Article | ovarian cancer
mdlinx.com — “Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort” View full resource at mdlinx.com
Most Recently Shared on September 2, 2011 at 5:09 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dr RY Zang just commented on: Predictors of survival in patients with recurrent ovarian cancer under... http://t.co/oeXOK6i #authorcmnt
Ovarian Cancer: Gynecologist Disputes Findings
medicalnewstoday.com — “An internationally-recognized gynecologic oncologist at St. Joseph's Hospital and Medical Center in Phoenix, Arizona is warning that the results from a long-awaited global study of ovarian cancer” View full resource at medicalnewstoday.com
Most Recently Shared on October 18, 2010 at 1:05 pm By:
MNT Clinical Trials Health News
Ovarian Cancer: Gynecologist Disputes Findings http://mnt.to/3Lm8 #clinicaltrials
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modes” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence http://mnt.to/3NP9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
